Relmada Therapeutics Depreciation & Amortization 2011-2026 | RLMD

Annual Depreciation & Amortization Relmada Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	1.26 K	3.75 K	4.36 K	2.63 K	85.3 K	54.8 K	9.26 K	-	373	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
85.3 K	373	20.2 K

Quarterly Depreciation & Amortization Relmada Therapeutics

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.26 K	1.26 K	806	-	2.93 K	2.08 K	1.05 K	-	1.1 K	2.16 K	1.08 K	-	1.4 K	2.71 K	1.4 K	-	548	1.13 K	548	-	20.2 K	43.7 K	20.2 K	-	2.95 K	5.91 K	2.95 K	-	3.59 K	3.5 K	3.59 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
43.7 K	548	5.33 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.18	1.92 %	$ 44.7 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.68	-0.7 %	$ 2.07 B	Canada
Harrow Health HROW	1.32 M	$ 37.94	2.27 %	$ 1.39 B	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.09	0.93 %	$ 117 M	Canada
Jupiter Wellness JUPW	654 K	-	-	$ 33.6 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
Evolus EOLS	7.51 M	$ 4.44	2.54 %	$ 286 M	USA
Emergent BioSolutions EBS	125 M	$ 8.66	5.1 %	$ 443 M	USA
Tilray TLRY	35.7 M	$ 6.91	2.83 %	$ 4.27 B	Canada
Organogenesis Holdings ORGO	13.6 M	$ 2.51	5.46 %	$ 330 M	USA
Pacira BioSciences PCRX	78.8 M	$ 23.75	-1.29 %	$ 1.1 B	USA
Veru VERU	268 K	$ 2.42	1.68 %	$ 326 M	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Viatris VTRS	2.74 B	$ 13.91	0.58 %	$ 16.7 B	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
cbdMD YCBD	452 K	$ 0.73	-2.28 %	$ 3.15 M	USA
Assertio Holdings ASRT	30 M	$ 18.02	-	$ 115 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	580 K	$ 1.02	0.99 %	$ 50.9 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	1.64 M	$ 8.23	-1.91 %	$ 720 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.18	-7.23 %	$ 2.71 M	USA
Zomedica Corp. ZOM	2.06 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	2.19 M	$ 0.93	-1.38 %	$ 33.5 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	1.5 M	$ 0.63	-3.05 %	$ 2.7 M	China
TherapeuticsMD TXMD	384 K	$ 2.11	2.93 %	$ 24.4 M	USA